moxalactam has been researched along with Meningitis, Meningococcal, Serogroup A in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| da Silva, HR; Freedman, JM; Hoffman, SH; Lynch, MA; Rocha, H; Sande, MA; Scheld, WM | 1 |
| Anderson, DC; Feigin, RD; Garcia, H; Kaplan, SL; Kvernland, SJ; Loiselle, EM; Mason, EO; Mintz, AA | 1 |
| Fujii, R; Hashira, S; Maruyama, S; Oka, T; Sanae, N; Sunakawa, K; Takimoto, M; Tojo, M; Tsuchida, A; Yoshioka, H | 1 |
3 other study(ies) available for moxalactam and Meningitis, Meningococcal, Serogroup A
| Article | Year |
|---|---|
Moxalactam for the treatment of bacterial meningitis in children.
Topics: Adolescent; Ampicillin; Biological Availability; Child; Child, Preschool; Drug Therapy, Combination; Haemophilus influenzae; Humans; Infant; Meningitis, Haemophilus; Meningitis, Meningococcal; Moxalactam; Neisseria meningitidis | 1983 |
Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis.
Topics: Blood-Brain Barrier; Cephalosporins; Cephamycins; Child; Child, Preschool; Dose-Response Relationship, Drug; Humans; Infant; Kinetics; Meningitis, Haemophilus; Meningitis, Meningococcal; Meningitis, Pneumococcal; Moxalactam | 1981 |
[Pharmacokinetic and clinical studies of latamoxef (moxalactam) in neonates and premature infants].
Topics: Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Infusions, Parenteral; Injections, Intravenous; Kinetics; Meningitis, Meningococcal; Moxalactam; Staphylococcus aureus; Streptococcus pneumoniae; Urinary Tract Infections | 1984 |